Skip to main content

Advertisement

Log in

Preimplantation Genetic Testing for Inherited Heart Diseases

  • Review
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Preimplantation genetic testing for monogenic conditions (PGT-M) is an increasingly utilized reproductive technology for patients with inherited heart disease (IHD). In this article, we provide an overview of the PGT-M process, including current guidance about its use, and review recent data about the perspectives and experiences of patients considering the use of PGT-M.

Recent Findings

PGT-M is used for a variety of IHDs; however, there is evidence that providers do not consistently raise this topic with patients, which may be due to a lack of knowledge about PGT-M. Regardless of the condition, patients report similar motivations for using PGT-M, such as the desire for a healthy child and the wish to save offspring from suffering. Patients make individualized decisions that are influenced by their lived experience with the diagnosis, a sense of responsibility to prevent disease transmission and other personal and logistical considerations. The PGT-M process can be challenging and each patient requires comprehensive information and support throughout.

Summary

PGT-M is a complex multi-step process whereby individual decision-making is influenced by various intrinsic and extrinsic factors. Adequate information and support are necessary for individual decision-making and expectation-setting. This is best accomplished by a multidisciplinary collaboration including cardiology, genetics, reproductive endocrinologists, and obstetric providers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

ART:

Assisted reproductive technology

CV:

Cardiovascular

GC:

Genetic counseling

GT:

Genetic testing

IHD:

Inherited heart disease

IVF:

In vitro fertilization

PGT:

Preimplantation genetic testing

PGT-A:

PGT for aneuploidy

PGT-SR:

PGT for structural rearrangements

PGT-M:

PGT for monogenic disorders

SCD:

Sudden cardiac death

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Musunuru K, Hershberger RE, Day SM, Klinedinst NJ, Landstrom AP, Parikh VN, et al. Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association. Circ Genom Precis Med. 2020;13(4):e000067.

    Article  PubMed  Google Scholar 

  2. Stiles MK, Wilde AAM, Abrams DJ, Ackerman MJ, Albert CM, Behr ER, et al. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. Heart Rhythm. 2021;18(1):e1–50.

    Article  PubMed  Google Scholar 

  3. Wilde AAM, Semsarian C, Márquez MF, Shamloo AS, Ackerman MJ, Ashley EA, et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert consensus statement on the state of genetic testing for cardiac diseases. EP Europace. 2022;24(8):1307–67.

    Article  Google Scholar 

  4. Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, De Mouzon J, Sokol R, Rienzi L, Sunde A, Schmidt L, Cooke ID, Simpson JL. The international glossary on infertility and fertility care, 2017. Fertil Steril. 2017;108(3):393–406.

    Article  PubMed  Google Scholar 

  5. ACOG Committee Opinion. Preimplantation genetic testing, Number 799. Obstet Gynecol. 2020;135(3):e133–7.

    Article  Google Scholar 

  6. De Rycke M, Berckmoes V. Preimplantation genetic testing for monogenic disorders. Genes. 2020;11(8):871.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kuliev A, Pakhalchuk T, Prokhorovich M, Rechitsky S. Preimplantation genetic testing for inherited predisposition to cardiac disease. Ann Heart. 2021;5(1). https://scholars.direct/Articles/heart/ahe-5-019.php?jid=heart. Kuliev et al. discuss outcomes of PGT-M cycles for inherited cardiac diseases. 109 cycles resulted in 54 liveborn children without the variant. The most common indication for PGT-M in this cohort was hypertrophic cardiomyopathy, with variants in MYBPC3 being the most prevalent. The article discusses the increasing usage of PGT-M for inherited cardiac diseases to prevent adverse outcomes like premature sudden death in offspring.

  8. Daar J, Benward J, Collins L, Davis J, Davis O, Francis L, et al. Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion. Fertil Steril. 2018;109(6):989–92.

    Article  Google Scholar 

  9. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Penzias A, Azziz R, Bendikson K, Cedars M, Falcone T, Hansen K, Hill M, Jindal S, Kalra S, Mersereau J, Racowsky C. Fertility evaluation of infertile women: a committee opinion. Fertil Steril. 2021;116(5):1255–65.

    Article  Google Scholar 

  11. ESHRE PGT Consortium Steering Committee, Carvalho F, Coonen E, Goossens V, Kokkali G, Rubio C, et al. ESHRE PGT Consortium good practice recommendations for the organisation of PGT. Hum Reprod Open. 2020;2020(3):hoaa021.

    Article  PubMed Central  Google Scholar 

  12. Gurevich R. Verywell Family. 2021 PGT-M and PGT-A screening to reduce the risk of passing genetic diseases. https://www.verywellfamily.com/pgd-and-pgs-genetic-screening-before-ivf-4151705

  13. Mathiesen A, Roy K. In: Baty B, editor. Foundations of perinatal genetic counseling : a guide for counselors. Oxford; New York: Oxford University Press; 2018. p. 289.

    Google Scholar 

  14. ESHRE PGT-M Working Group, Carvalho F, Moutou C, Dimitriadou E, Dreesen J, Giménez C, et al. ESHRE PGT Consortium good practice recommendations for the detection of monogenic disorders†. Human Reprod Open. 2020;2020(3):hoaa018.

    Article  Google Scholar 

  15. Scott RT, Upham KM, Forman EJ, Zhao T, Treff NR. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil Steril. 2013;100(3):624–30.

    Article  PubMed  Google Scholar 

  16. Goisis A, Remes H, Martikainen P, Klemetti R, Myrskylä M. Medically assisted reproduction and birth outcomes: a within-family analysis using Finnish population registers. Lancet. 2019;393(10177):1225–32.

    Article  PubMed  Google Scholar 

  17. Hwang SS, Dukhovny D, Gopal D, Cabral H, Missmer S, Diop H, et al. Health of infants after ART-treated, subfertile, and fertile deliveries. Pediatrics. 2018;142(2):e20174069.

    Article  PubMed  Google Scholar 

  18. Liberman RF, Getz KD, Heinke D, Luke B, Stern JE, Declercq ER, et al. Assisted reproductive technology and birth defects: effects of subfertility and multiple births. Birth Defects Res. 2017;109(14):1144–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Khorshid A, Boyd ALH, Behr B, Zhao Q, Alvero R, Bavan B. Cost-effectiveness of IVF with PGT-M/A to prevent transmission of spinal muscular atrophy in offspring of carrier couples. J Assist Reprod Genet. 2023;40:793–801.

    Article  PubMed  Google Scholar 

  20. Lipton JH, Zargar M, Warner E, Greenblatt EE, Lee E, Chan KKW, et al. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations. Hum Reprod. 2020;35(2):434–45.

    Article  CAS  PubMed  Google Scholar 

  21. Bunnell ME, Dobson LJ, Lanes A, Ginsburg ES. Use of preimplantation genetic testing for monogenic disorders and subsequent prenatal care and diagnostic testing. Prenat Diagn. 2022;42(8):1022–30.

    Article  PubMed  Google Scholar 

  22. Rechitsky S, Kuliev A. Preimplantation genetic testing (PGT) for non-traditional indications. Reprod BioMed Online. 2019;38:e3.

    Article  Google Scholar 

  23. Tester DJ, Ackerman MJ. Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice. Circulation. 2011;123(9):1021–37.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Bayefsky M. Who should regulate preimplantation genetic diagnosis in the United States? AMA J Ethics. 2018;20(12):E1160–7.

    Article  PubMed  Google Scholar 

  25. Mital S, Musunuru K, Garg V, Russell MW, Lanfear DE, Gupta RM, et al. Enhancing literacy in cardiovascular genetics: a scientific statement from the American Heart Association. Circ Cardiovasc Genet. 2016;9(5):448–67.

    Article  CAS  PubMed  Google Scholar 

  26. Capelouto S, Evans M, Shannon J, Jetelina K, Bukulmez O, Carr B. Specialist physicians’ referral behavior regarding preimplantation genetic testing for single-gene disorders: is there room to grow? F S Rep. 2021;2(2):215–23.

    PubMed  PubMed Central  Google Scholar 

  27. Klitzman R. Challenges, Dilemmas and factors involved in PGD decision-making: providers’ and patients’ views, experiences and decisions. J Genet Couns. 2018;27(4):909–19.

    Article  PubMed  Google Scholar 

  28. Hughes T, Bracewell-Milnes T, Saso S, Jones BP, Almeida PA, Maclaren K, et al. A review on the motivations, decision-making factors, attitudes and experiences of couples using pre-implantation genetic testing for inherited conditions. Hum Reprod Update. 2021;27(5):944–66. Hughes et al. conducted a systematic literature review to report aspects of couples’ experiences with PGT. They used thematic analysis to summarize common patient motivations, attitudes, and decision-making factors and describe patient experiences with the decision process and the PGT process. The review provides insight on how to use these findings in clinical practice to best support patients considering PGT including holistic and thorough counseling and a multidisciplinary care team.

    Article  CAS  PubMed  Google Scholar 

  29. Lee I, Alur-Gupta S, Gallop R, Dokras A. Utilization of preimplantation genetic testing for monogenic disorders. Fertil Steril. 2020;114(4):854–60.

    Article  PubMed  Google Scholar 

  30. Yeates L, McDonald K, Burns C, Semsarian C, Carter S, Ingles J. Decision-making and experiences of preimplantation genetic diagnosis in inherited heart diseases: a qualitative study. Eur J Hum Genet. 2022;30(2):187–93. Yeates et al. conducted semi-structured interviews with 20 individuals recruited from a specialized cardiovascular genetics clinic in Australia to understand their experiences learning about and utilizing PGT-M for inherited cardiac conditions. Three themes emerged including the patient/family experience with the disease, familial and generational factors, and practical considerations which all impacted participants’ imagined future and their decision to pursue PGT-M or not. The article provides main points to discuss with patients/families considering PGT-M to best support families and highlights the benefit of a multidisciplinary specialized clinic in this setting.

    Article  PubMed  Google Scholar 

  31. Patton K, Wong EK, Cirino AL, Dobson LJ, Harris S. Reproductive decision-making and the utilization of preimplantation genetic testing among individuals with inherited aortic or vascular disease. J Genet Couns. 2023; https://doi.org/10.1002/jgc4.1759.

  32. Pastore LM, Cordeiro Mitchell CN, Rubin LR, Nicoloro-SantaBarbara J, Genoff Garzon MC, Lobel M. Patients’ preimplantation genetic testing decision-making experience: an opinion on related psychological frameworks. Hum Reprod Open. 2019;2019(4):hoz019.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Hershberger PE, Gallo AM, Kavanaugh K, Olshansky E, Schwartz A, Tur-Kaspa I. The decision-making process of genetically at-risk couples considering preimplantation genetic diagnosis: initial findings from a grounded theory study. Soc Sci Med. 2012;74(10):1536–43.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Cheng L, Meiser B, Kirk E, Kennedy D, Barlow-Stewart K, Kaur R. Factors influencing patients’ decision-making about preimplantation genetic testing for monogenic disorders. Hum Reprod. 2022;37(11):2599–610.

    Article  PubMed  Google Scholar 

  35. Mor P, Brennenstuhl S, Metcalfe KA. Uptake of preimplantation genetic diagnosis in female BRCA1 and BRCA2 Mutation Carriers. J Genet Couns. 2018;27(6):1386–94.

    Article  PubMed  Google Scholar 

  36. Zuckerman S, Gooldin S, Zeevi DA, Altarescu G. The decision-making process, experience, and perceptions of preimplantation genetic testing (PGT) users. J Assist Reprod Genet. 2020;37(8):1903–12.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Resta R, Biesecker BB, Bennett RL, Blum S, Estabrooks Hahn S, Strecker MN, et al. A new definition of genetic counseling: national society of genetic counselors’ task force report. J Genet Couns. 2006;15(2):77–83.

    Article  PubMed  Google Scholar 

  38. Arscott P, Caleshu C, Kotzer K, Kreykes S, Kruisselbrink T, Orland K, et al. A case for inclusion of genetic counselors in cardiac care. Cardiol Rev. 2016;24(2):49–55.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Platt J. A person-centered approach to cardiovascular genetic testing. Cold Spring Harb Perspect Med. 2020;10(7):a036624.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Bains S, Neves R, Bos JM, Giudicessi JR, MacIntyre C, Ackerman MJ. Phenotypes of overdiagnosed long QT syndrome. J Am Coll Cardiol. 2023;81(5):477–86.

    Article  CAS  PubMed  Google Scholar 

  41. Amendola LM, Jarvik GP, Leo MC, McLaughlin HM, Akkari Y, Amaral MD, et al. Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the clinical sequencing exploratory research consortium. Am J Hum Genet. 2016;98(6):1067–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Bland A, Harrington EA, Dunn K, Pariani M, Platt JCK, Grove ME, et al. Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experience. Genet Med. 2018;20(3):369–73.

    Article  PubMed  Google Scholar 

  43. Reuter C, Grove ME, Orland K, Spoonamore K, Caleshu C. Clinical cardiovascular genetic counselors take a leading role in team-based variant classification. J Genet Couns. 2018;27(4):751–60.

    Article  PubMed  Google Scholar 

  44. Wain KE, Azzariti DR, Goldstein JL, Johnson AK, Krautscheid P, Lepore B, et al. Variant interpretation is a component of clinical practice among genetic counselors in multiple specialties. Genet Med. 2020;22(4):785–92.

    Article  CAS  PubMed  Google Scholar 

  45. Porto A, Gaber Caffrey R, Crowley-Matoka M, Spencer S, Li M, Propst L. Offering preimplantation genetic testing for monogenic disorders (PGT-M) for conditions with reduced penetrance or variants of uncertain significance: ethical insight from U.S. laboratory genetic counselors. J Genet Couns. 2022;31(1):261–8.

    Article  PubMed  Google Scholar 

  46. Landry LG, Rehm HL. Association of racial/ethnic categories with the ability of genetic tests to detect a cause of cardiomyopathy. JAMA Cardiol. 2018;3(4):341.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Cheng L, Meiser B, Kirk E, Kennedy D, Barlow-Stewart K, Kaur R. Decisional needs of patients considering preimplantation genetic testing: a systematic review. Reprod Biomed Online. 2022;44(5):839–52.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Allison L Cirino.

Ethics declarations

Conflict of Interest

Chelsea Stevens declares that she has no conflict of interest related to this work.

Robyn Hylind that she has no conflict of interest related to this work.

Sophie Adams declares she has no conflicts of interest related to this work.

Allison Cirino that she has no conflict of interest related to this work.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stevens, C., Hylind, R., Adams, S. et al. Preimplantation Genetic Testing for Inherited Heart Diseases. Curr Cardiovasc Risk Rep 17, 195–203 (2023). https://doi.org/10.1007/s12170-023-00727-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12170-023-00727-0

Keywords

Navigation